$40 Trillion and Parents' Night Out Plus: ICE chillin', Moderna-Merck melanoma advances, and more... Reason · Aug 20
Stocks Slip Before the Open as Bond Rout Resumes; Walmart Sinks After Earnings September S&P 500 E-Mini futures (ESU26) are down -0.37%, and September Nasdaq 100 E-Mini futures (NQU26) are down -0.48% this morning, pointing to a lower open on Wall Street as Treasury yields resumed their climb. Barchart · Aug 20
How does Moderna’s new melanoma vaccine work – and could it treat other cancers? Melanoma is the most aggressive form of skin cancer causing about 2,600 deaths a year in the UK The Independent UK · Aug 20
A Custom mRNA Therapy Built from Each Patient's Tumor Improved Melanoma Recurrence-Free Survival in a Phase 3 Trial Merck and Moderna say intismeran autogene plus Keytruda met its primary endpoint in a Phase 3 melanoma trial. What the topline result does and does not show. Medical Daily · Aug 20
Global Market: China, Hong Kong stocks rebound as healthcare and tech shares rally China and Hong Kong stocks rebounded on Thursday, led by healthcare and technology shares, after a sharp selloff in the previous session. Fresh share buyback announcements also supported sentiment, while gains in South Korea and Japan helped broader Asian markets recover. Investors remained cautious amid heightened volatility. The Economic Times · Aug 20
Short Sellers Just Lost $5B on the Wrong Pharma Bet: Cancer Vaccine Sends Stock Soaring 177% Moderna's shares surged 177% after positive cancer vaccine trial results, causing $5 billion losses for short sellers. This marks a potential shift beyond its COVID-19 vaccine business. International Business Times UK · Aug 20
Moderna's Personalised Cancer Vaccine Clears Phase 3: How Soon Could Patients Receive It? Moderna and Merck's personalised cancer vaccine shows positive Phase 3 results, reducing melanoma recurrence risk. Regulatory approval is pending, with potential market availability by 2027. International Business Times UK · Aug 20
Moderna, Merck breakthrough could usher in wave of cancer vaccines Merck and Moderna's personalized cancer vaccine shows promise for melanoma patients. This new treatment trains the immune system to target specific tumor mutations. The vaccine, combined with Keytruda, significantly reduced cancer recurrence in trials. Doctors are hopeful this approach will expand to treat many other cancer types. Further trials are… The Economic Times · Aug 20
Elon Musk Says mRNA Has 'Tremendous Promise,' Turning Disease Into a 'Software Problem,' as Moderna Stock Rockets 177% on Cancer Vaccine Breakthrough Elon Musk said Wednesday that mRNA technology could fundamentally change how diseases are treated, a shift that would make medicine more of a software problem than a biological one, as Moderna Inc. (NASDAQ:MRNA) and Merck & Co Inc. (NYSE:MRK) posted a major cancer-vaccine trial win. Benzinga · Aug 20
Moderna, Webull, Bitmine Immersion, Strategy and Merck: Why These 5 Stocks Are on Investors' Radars Today Major U.S. indices closed higher on Wednesday, with the Dow Jones Industrial Average rising 0.22% to 53,463.05, the S&P 500 gaining 0.21% to 7,707.98 and the Nasdaq advancing 0.16% to 26,331.09. Benzinga · Aug 20
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For Moderna Inc.’s (NASDAQ:MRNA) latest cancer-vaccine breakthrough could be doing more than sending its stock sharply higher. It may be giving investors a reason to revisit an mRNA investment thesis that has largely been defined by COVID-19. ETFs tied to precision medicine names are also getting a boost. Benzinga · Aug 19
Moderna Stock Soars More Than 100% on Cancer Vaccine Breakthrough: What Investors Are Betting On Moderna shares surged after its personalised mRNA cancer treatment met key Phase 3 trial endpoints in melanoma with Merck's Keytruda. International Business Times UK · Aug 19
Stocks Finish Mixed as Bond Yields Fall and Chipmakers Slide The S&P 500 Index ($SPX ) (SPY ) closed up by +0.21% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.22%. E-mini S&P futures (ESU26 ) rose +0.20%, and September E-mini... Barchart · Aug 19
Stocks Snap Losing Streak as Treasury Yields Ease: Stock Market Today Yields on the 10-year and 30-year Treasuries pulled back Wednesday after the Treasury Department announced new buyback levels. Kiplinger · Aug 19
Benzinga · Aug 19 Trump Adds to Wealth With Moderna Stock Gains: Here’s How Much President Made Moderna Inc. (NASDAQ:MRNA) stock soared Wednesday after the company and Merck reported positive Phase 3 results for a personalized mRNA cancer vaccine, marking a major milestone for the emerging technology. Shares jumped more than 100%, reaching levels not seen since May 2024.
The Economic Times · Aug 19 US stocks: US market rises as yields ease, Moderna lifts healthcare stocks US stock markets enjoyed a boost as easing bond yields and a spike in Moderna shares contributed to a favorable trading environment. Despite the Federal Reserve's minutes highlighting inflation concerns and discussions on rate hikes, investors remained optimistic. The Treasury's announcement of liquidity support revitalized riskier assets, particularly in tech…
Bangkok Post · Aug 19 'Breakthrough' mRNA cancer drug curbs melanoma in large trial WASHINGTON (UNITED STATES) - US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough."
Reason · Aug 19 Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers The vaccine could be available as soon as 2027.
Fortune · Aug 19 Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.
Benzinga · Aug 19 Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today U.S. equities clawed back Tuesday’s tech-led slump by midday Wednesday as the Treasury’s decision to double its long-dated debt buybacks pulled benchmark yields off 20-month highs and knocked the dollar to its weakest level since late May.
Barchart · Aug 19 This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results Moderna stock rips higher on a major cancer breakthrough. The announcement led William Blair to upgrade MRNA shares to "Outperform."
The Independent UK · Aug 19 Moderna stock more than doubles after skin cancer breakthrough announcement IN FULL
International Business Times UK · Aug 19 Moderna Shares Double Overnight Because a Made-to-Order mRNA Vaccine Actually Beats Skin Cancer Moderna's personalised mRNA cancer vaccine, intismeran, significantly reduces melanoma recurrence in a Phase 3 trial, doubling the company's stock value and marking a milestone in cancer treatment.
The Independent UK · Aug 19 Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test Moderna shares more than doubled after announcing initial results from a study of an experimental cancer treatment
Barchart · Aug 19 Stocks Supported by Lower Bond Yields The S&P 500 Index ($SPX ) (SPY ) is up by +0.58% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.07%. E-mini S&P futures (ESU26 ) are up +0.61%, and September E-mini...